During the corresponding time, Oculis Holding Ag recorded a revenue increase by 85.72 % year on year, While revenue at the Oculis Holding Ag's corporate clients
Oculis Holding Ag's Comment on Sales, Marketing and Customers
The text outlines federal and state laws and regulations relevant to healthcare providers, health plans, healthcare clearinghouses, business associates, pharmaceutical manufacturers, and healthcare professionals, including doctors, dentists, optometrists, podiatrists, chiropractors, physician assistants, nurse practitioners, and teaching hospitals. It also references third-party payors such as Medicare, Medicaid, the Children’s Health Insurance Program, private insurers, and patients.
Oculis Holding AG, a global biopharmaceutical company dedicated to saving sight and enhancing eye care, recently reported the successful enrollment completion of its Phase 2 ACUITY trial. This trial aims to evaluate the safety and tolerability of their novel drug candidate, OCS-05, in patients diagnosed with Acute Optic Neuritis (AON). The company also provided updates on their late-stage clinical trials and announced key leadership appointments during its RandD Day.Oculis Phase 2 ACUITY Trial:The multi-center, randomized, double-blind, placebo-controlled Phase 2 ACUITY trial focuses on assessing the safety and tolerability of OCS-05 in patients suffering from AON. Acute Optic Neuritis, characterized by inf...
Oculis Holding Ag’s Comment on Sales, Marketing and Customers
The text outlines federal and state laws and regulations relevant to healthcare providers, health plans, healthcare clearinghouses, business associates, pharmaceutical manufacturers, and healthcare professionals, including doctors, dentists, optometrists, podiatrists, chiropractors, physician assistants, nurse practitioners, and teaching hospitals. It also references third-party payors such as Medicare, Medicaid, the Children’s Health Insurance Program, private insurers, and patients.
Sources:
Oculis Holding Ag’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Oculis Holding Ag’s corporate clients.
For your research, we’ve provided 9 tables on Oculis Holding Ag corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
